STAT+: Divergent trial results on cancer vaccines have the field grappling with hard questions

According to STAT+, a melanoma vaccine succeeded in a late-stage clinical trial. With divergent results across the cancer vaccine field, the question now is whether other cancer vaccines will work — and whether mRNA is up to the task.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.